<DOC>
	<DOCNO>NCT03009019</DOCNO>
	<brief_summary>Efficacy , Tolerability , Safety DFN-15 episodic migraine without aura , conduct multiple center United States</brief_summary>
	<brief_title>Efficacy , Tolerability , Safety DFN-15</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>1 . A history episodic migraine , experience 2 8 migraine attack per month least past 12 month , 14 headache day per month , 48 hour headachefree time migraine attack . 2 . Patients migraine without aura onset age 50 year 3 . Report usual migraine pain 2 ( moderate ) 3 ( severe ) headache pain severity scale without treatment . 4 . Subjects willing able : 1 . Evaluate record pain , migraine symptom , study drug effectiveness information realtime use subject eDiary duration study ; 2 . Record instance use study drug rescue medication realtime use subject eDiary duration study ; 3 . Comply study procedure schedule requirement . 1 . Minors , even specify study age range 2 . Medication overuse : 1 . Opioids great equal 10 day 90 day prior screen 2 . Combination medication ( e.g. , Fiorinal® ) great equal 10 day 90 day prior screen ( applies include opioid and/or barbiturate ) 3 . Nonsteroidal Antiinflammatory Drugs simple medication great 14 day month 90 day prior screen 4 . Triptans ergots great equal 10 day month 90 day prior screen 3 . Treated onabotulinumtoxin A ( Botox® ) migraine within 4 month prior screen . ( If treat cosmetic reason , subject may include ) . 4 . Current treatment antipsychotic use antipsychotic within 30 day prior randomization . 5 . Patients receive treatment investigational drug device within 30 day randomization , participated central nervous system clinical trial within 2 month prior randomization 6 . Patients positive screen test human immunodeficiency virus [ HIV ] , positive hepatitis B surface antigen ( HBsAg ) , positive hepatitis C virus [ HCV ] antibody 7 . Subjects employee immediate relative employee Sponsor , affiliate partner , clinical research study site .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>